New from NCI |
Studying “Total Diet” and Its Impact on Health, Including Cancer Risk |
| | Researchers have begun taking a more holistic approach to nutrition research, looking at dietary patterns across the lifespan versus individual foods or nutrients. Learn how research on the connection between diet and disease is evolving. |
Immunotherapy Drug Approved for Advanced Squamous Cell Skin Cancer |
| | The Food and Drug Administration (FDA) approved the immunotherapy drug cemiplimab (Libtayo) for an advanced form of cutaneous squamous cell carcinoma (SCC), a common type of skin cancer. It is the first agent to be approved specifically for advanced SCC. |
CAR T-Cell Therapy Infographic
This illustration shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells are changed in the laboratory so they will attack cancer cells. T cells are part of the immune system. |
Cancer in Children and Adolescents
This recently updated page covers statistics, types, causes, and treatment of childhood cancers in the United States.
|
PDQ Summary Updates |
Childhood Craniopharyngioma Treatment
We’ve updated our childhood craniopharyngioma summary to include intracavitaryinterferon-alfa as a standard treatment for this disease.
|
Drug Information Updates |
Dacomitinib for Non-Small Cell Lung Cancer
We’ve added a new drug information summary for dacomitinib (Vizimpro). It was recently approved by FDA as first-line treatment for non-small cell lung cancer in patients whose tumors have certain mutations in the EGFR gene. |
New Drug for Leukemia and Lymphomas
We’ve added a new drug information summary for duvelisib (Copiktra). It was recently approved by FDA to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or follicular lymphoma that came back or did not respond to treatment after at least two other therapies. |
No hay comentarios:
Publicar un comentario